February 6, 2003
CPTech Notes on Pharmaceutical Pricing Agreement Between U.S and Korea. The agreement comes after years of pressure from the U.S., and ties the price of drugs in Korea to the price of drugs in the United States, United Kingdom, Germany, France, Italy, Switzerland, and Japan.
From: heeseob_n
To: ip-health@lists.essential.org
Sent: Friday, February 07, 2003 1:52 AM
Subject: Leukemia Patients Arrest by Police Force
Today morning Korean leukemia patients and NGO members visited Novartis Korea to ask a meeting with Mr. Bobe, a president of Novartis Korea. We planed in this meeting to discuss possible ways to solve current problems of access to Glivec, cancer durg patented and solely sold by Novartis. However, in our four-hours protests, we are arrested by the policy officials. In this process, two injured patients are sent to hospital by an ambulance car. You can see the story at http://www.withnews.com/read.php3?no=192#
| Return to: CPTech Home -> Main IP Page -> IP and Healthcare -> Gleevec Page |